Roche's (RHHBY) Genentech Receives FDA Committee Nod for Lucentis as DME Treatment
Go back to Roche's (RHHBY) Genentech Receives FDA Committee Nod for Lucentis as DME Treatment| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 55.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.53 | 52 Week High | $35.13 | |||
| Open | $55.53 | 52 Week Low | $28.10 | |||
| Day High | $55.53 | P/E | N/A | |||
| Day Low | $55.53 | EPS | $0.00 | |||
| Volume | 437 | |||||
